Deciphera Pharmaceuticals LLC (DCPH) Insider Trading
- $51,164,768.00
- $64,039,566.59
- Jan. 24, 2023
- Michael Douglas Taylor
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 24, 2023 | Major Shareholder | 1,666,666 | $18.00 | Buy | $29,999,988.00 | |
| Jan. 17, 2023 | Insider | 2,403 | $21.24 | Sell | $51,039.72 | |
| Oct. 3, 2022 | EVP | 2,587 | $18.73 | Sell | $48,454.51 | |
| June 16, 2022 | EVP | 1,768 | $10.75 | Sell | $19,006.00 | |
| June 16, 2022 | Insider | 1,298 | $10.75 | Sell | $13,953.50 | |
| April 29, 2022 | Major Shareholder | 1,478,978 | $10.00 | Buy | $14,789,780.00 | |
| Feb. 16, 2022 | Insider | 1,366 | $9.05 | Sell | $12,362.30 | |
| Feb. 16, 2022 | EVP | 984 | $9.05 | Sell | $8,905.20 | |
| Feb. 16, 2022 | CFO | 1,368 | $9.05 | Sell | $12,380.40 | |
| Oct. 4, 2021 | EVP | 2,659 | $33.17 | Sell | $88,199.03 | |
| April 19, 2021 | Director | 5,300 | $46.26 | Sell | $245,178.00 | |
| April 12, 2021 | Director | 14,700 | $43.84 | Sell | $644,448.00 | |
| April 1, 2021 | Director | 8,000 | $45.57 | Sell | $364,560.00 | |
| Jan. 4, 2021 | Director | 19,000 | $56.45 | Sell | $1,072,550.00 | |
| Dec. 1, 2020 | Director | 19,000 | $60.90 | Sell | $1,157,100.00 | |
| Sept. 10, 2020 | CFO | 3,000 | $47.71 | Sell | $143,130.00 | |
| Sept. 8, 2020 | CFO | 6,000 | $45.49 | Sell | $272,940.00 | |
| July 9, 2020 | Director | 23,541 | $54.99 | Sell | $1,294,519.59 | |
| July 6, 2020 | Director | 27,544 | $55.22 | Sell | $1,520,979.68 | |
| July 2, 2020 | Director | 48,245 | $56.69 | Sell | $2,735,009.05 | |
| June 5, 2020 | Director | 5,635 | $55.90 | Sell | $314,996.50 | |
| June 3, 2020 | Director | 6,365 | $59.14 | Sell | $376,426.10 | |
| May 11, 2020 | CFO | 12,000 | $55.19 | Sell | $662,280.00 | |
| April 28, 2020 | Director | 25,000 | $56.90 | Sell | $1,422,500.00 | |
| April 17, 2020 | Director | 23,892 | $46.67 | Sell | $1,115,039.64 | |
| April 14, 2020 | Director | 1,108 | $46.71 | Sell | $51,754.68 | |
| April 9, 2020 | Director | 23,542 | $43.83 | Sell | $1,031,845.86 | |
| April 1, 2020 | Director | 75,000 | $37.57 | Sell | $2,817,750.00 | |
| Jan. 24, 2020 | Director | 25,000 | $66.13 | Sell | $1,653,250.00 | |
| Jan. 22, 2020 | Insider | 26,999 | $67.18 | Sell | $1,813,792.82 | |
| Jan. 15, 2020 | Insider | 12,023 | $65.23 | Sell | $784,260.29 | |
| Jan. 7, 2020 | Insider | 1,650 | $60.02 | Sell | $99,033.00 | |
| Jan. 3, 2020 | Director | 31,422 | $57.31 | Sell | $1,800,794.82 | |
| Jan. 3, 2020 | CFO | 4,359 | $57.35 | Sell | $249,988.65 | |
| Jan. 2, 2020 | Insider | 16,137 | $58.55 | Sell | $944,821.35 | |
| Dec. 12, 2019 | Insider | 15,034 | $60.00 | Sell | $902,040.00 | |
| Dec. 3, 2019 | Insider | 15,034 | $51.38 | Sell | $772,446.92 | |
| Nov. 11, 2019 | Insider | 152,927 | $48.91 | Sell | $7,479,659.57 | |
| Nov. 1, 2019 | Director | 25,000 | $46.16 | Sell | $1,154,000.00 | |
| Oct. 28, 2019 | Insider | 29,820 | $44.34 | Sell | $1,322,218.80 | |
| Oct. 28, 2019 | CFO | 3,750 | $44.34 | Sell | $166,275.00 | |
| Sept. 19, 2019 | Insider | 3,000 | $35.56 | Sell | $106,680.00 | |
| Sept. 11, 2019 | CFO | 11,250 | $34.97 | Sell | $393,412.50 | |
| Sept. 11, 2019 | Director | 22,500 | $34.97 | Sell | $786,825.00 | |
| Sept. 3, 2019 | Director | 7,500 | $36.26 | Sell | $271,950.00 | |
| Aug. 16, 2019 | Major Shareholder | 350,000 | $36.42 | Sell | $12,747,000.00 | |
| Aug. 13, 2019 | CFO | 11,250 | $41.27 | Sell | $464,287.50 | |
| Aug. 13, 2019 | Insider | 148,107 | $40.92 | Sell | $6,060,538.44 | |
| Aug. 13, 2019 | Director | 22,500 | $40.77 | Sell | $917,325.00 | |
| June 19, 2019 | CFO | 177 | $25.00 | Sell | $4,425.00 |
Insiders are both buying and selling Deciphera Pharmaceuticals LLC stock.
The insider traders at Deciphera Pharmaceuticals LLC are: Michael Douglas Taylor, Thomas Patrick Kelly, James Arthur Bristol, Daniel Lee Flynn, Christopher John Morl, Matthew L Sherman, Patricia L Allen, Brightstar Associates Llc, Daniel C Martin, New Leaf Venture Management Ii, and Jama Pitman
The most active insider trader at Deciphera Pharmaceuticals LLC is Michael Douglas Taylor with 16 trades.
New Leaf Venture Management Ii has sold the most Deciphera Pharmaceuticals LLC stock with a total value of $25,494,000.00.
Brightstar Associates Llc has bought the most Deciphera Pharmaceuticals LLC stock with a total value of $74,789,756.00.
The most recent insider trade for Deciphera Pharmaceuticals LLC was on Jan. 24, 2023.
The single biggest insider buy for Deciphera Pharmaceuticals LLC was from Brightstar Associates Llc with a total value of $29,999,988.00 on Jan. 24, 2023.
The single biggest insider sell for Deciphera Pharmaceuticals LLC was from New Leaf Venture Management Ii with a total value of $12,747,000.00 on Aug. 16, 2019.